Annual Shareholders Equity
-$32.06 M
-$68.14 M-188.87%
December 31, 2023
Summary
- As of February 8, 2025, ARMP annual stockholders equity is -$32.06 million, with the most recent change of -$68.14 million (-188.87%) on December 31, 2023.
- During the last 3 years, ARMP annual shareholders equity has fallen by -$50.92 million (-270.04%).
- ARMP annual shareholders equity is now -150.55% below its all-time high of $63.43 million, reached on December 31, 2000.
Performance
ARMP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$50.97 M
-$4.87 M-10.57%
September 30, 2024
Summary
- As of February 8, 2025, ARMP quarterly stockholders equity is -$50.97 million, with the most recent change of -$4.87 million (-10.57%) on September 30, 2024.
- Over the past year, ARMP quarterly shareholders equity has dropped by -$38.59 million (-311.54%).
- ARMP quarterly shareholders equity is now -170.44% below its all-time high of $72.36 million, reached on September 30, 2000.
Performance
ARMP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ARMP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -188.9% | -311.5% |
| 3 y3 years | -270.0% | -314.6% |
| 5 y5 years | -478.4% | -381.1% |
ARMP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -188.9% | at low | -182.8% | +9.8% |
| 5 y | 5-year | -188.9% | at low | -182.8% | +9.8% |
| alltime | all time | -150.6% | at low | -170.4% | +9.8% |
Armata Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$50.97 M(+10.6%) |
| Jun 2024 | - | -$46.10 M(-18.4%) |
| Mar 2024 | - | -$56.51 M(+76.2%) |
| Dec 2023 | -$32.06 M(-188.9%) | -$32.06 M(+158.9%) |
| Sep 2023 | - | -$12.39 M(-164.7%) |
| Jun 2023 | - | $19.14 M(-14.7%) |
| Mar 2023 | - | $22.45 M(-37.8%) |
| Dec 2022 | $36.08 M(+42.1%) | $36.08 M(-20.8%) |
| Sep 2022 | - | $45.58 M(-14.5%) |
| Jun 2022 | - | $53.29 M(-13.4%) |
| Mar 2022 | - | $61.54 M(+142.3%) |
| Dec 2021 | $25.40 M(+34.7%) | $25.40 M(+6.9%) |
| Sep 2021 | - | $23.75 M(-17.0%) |
| Jun 2021 | - | $28.62 M(-15.9%) |
| Mar 2021 | - | $34.01 M(+80.4%) |
| Dec 2020 | $18.86 M(+29.2%) | $18.86 M(-23.4%) |
| Sep 2020 | - | $24.62 M(-16.9%) |
| Jun 2020 | - | $29.64 M(-11.5%) |
| Mar 2020 | - | $33.48 M(+129.4%) |
| Dec 2019 | $14.59 M(+72.2%) | $14.59 M(-19.5%) |
| Sep 2019 | - | $18.13 M(-19.9%) |
| Jun 2019 | - | $22.63 M(+356.2%) |
| Mar 2019 | - | $4.96 M(-41.5%) |
| Dec 2018 | $8.47 M(+9.6%) | $8.47 M(+23.7%) |
| Sep 2018 | - | $6.85 M(-17.8%) |
| Jun 2018 | - | $8.34 M(-26.1%) |
| Mar 2018 | - | $11.29 M(+46.0%) |
| Dec 2017 | $7.73 M(-20.5%) | $7.73 M(-20.8%) |
| Sep 2017 | - | $9.76 M(-1.1%) |
| Jun 2017 | - | $9.86 M(+48.3%) |
| Mar 2017 | - | $6.65 M(-31.6%) |
| Dec 2016 | $9.72 M(-23.5%) | $9.72 M(-46.7%) |
| Sep 2016 | - | $18.23 M(-15.2%) |
| Jun 2016 | - | $21.48 M(+141.5%) |
| Mar 2016 | - | $8.90 M(-30.0%) |
| Dec 2015 | $12.71 M(+269.9%) | $12.71 M(-18.8%) |
| Sep 2015 | - | $15.66 M(+19.7%) |
| Jun 2015 | - | $13.09 M(-525.5%) |
| Mar 2015 | - | -$3.08 M(-189.5%) |
| Dec 2014 | $3.44 M(-115.2%) | $3.44 M(-69.7%) |
| Sep 2014 | - | $11.34 M(-225.7%) |
| Jun 2014 | - | -$9.02 M(-62.6%) |
| Mar 2014 | - | -$24.11 M(+6.6%) |
| Dec 2013 | -$22.63 M(-274.8%) | -$22.63 M(-927.8%) |
| Dec 2012 | $12.94 M(-443.1%) | - |
| Sep 2009 | - | $2.73 M(+38.2%) |
| Jun 2009 | - | $1.98 M(-136.6%) |
| Mar 2009 | - | -$5.40 M(+43.3%) |
| Dec 2008 | -$3.77 M(-123.2%) | -$3.77 M(-154.3%) |
| Sep 2008 | - | $6.94 M(-26.7%) |
| Jun 2008 | - | $9.46 M(-27.3%) |
| Mar 2008 | - | $13.02 M(-19.8%) |
| Dec 2007 | $16.24 M | $16.24 M(-22.2%) |
| Sep 2007 | - | $20.87 M(-12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $23.78 M(+141.6%) |
| Mar 2007 | - | $9.84 M(+83.4%) |
| Dec 2006 | $5.37 M(-82.4%) | $5.37 M(+261.7%) |
| Sep 2006 | - | $1.48 M(-66.1%) |
| Jun 2006 | - | $4.38 M(-86.3%) |
| Mar 2006 | - | $31.91 M(+4.4%) |
| Dec 2005 | $30.57 M(-38.6%) | $30.57 M(-10.5%) |
| Sep 2005 | - | $34.17 M(-14.1%) |
| Jun 2005 | - | $39.80 M(-11.7%) |
| Mar 2005 | - | $45.10 M(-9.4%) |
| Dec 2004 | $49.76 M(+48.6%) | $49.76 M(+8.2%) |
| Sep 2004 | - | $46.00 M(-5.6%) |
| Jun 2004 | - | $48.71 M(-8.4%) |
| Mar 2004 | - | $53.18 M(+58.9%) |
| Dec 2003 | $33.48 M(+467.8%) | $33.48 M(-15.8%) |
| Sep 2003 | - | $39.77 M(+51.0%) |
| Jun 2003 | - | $26.33 M(+419.8%) |
| Mar 2003 | - | $5.07 M(-14.1%) |
| Dec 2002 | $5.90 M(-76.8%) | $5.90 M(-50.4%) |
| Sep 2002 | - | $11.88 M(-5.6%) |
| Jun 2002 | - | $12.58 M(-59.5%) |
| Mar 2002 | - | $31.03 M(+22.2%) |
| Dec 2001 | $25.39 M(-60.0%) | $25.39 M(-43.9%) |
| Sep 2001 | - | $45.21 M(-16.5%) |
| Jun 2001 | - | $54.17 M(-8.9%) |
| Mar 2001 | - | $59.49 M(-6.2%) |
| Dec 2000 | $63.43 M(+806.2%) | $63.43 M(-12.3%) |
| Sep 2000 | - | $72.36 M(+153.0%) |
| Jun 2000 | - | $28.60 M(-12.2%) |
| Mar 2000 | - | $32.59 M(+365.6%) |
| Dec 1999 | $7.00 M(-41.7%) | $7.00 M(-29.3%) |
| Sep 1999 | - | $9.90 M(+50.0%) |
| Jun 1999 | - | $6.60 M(-29.0%) |
| Mar 1999 | - | $9.30 M(-22.5%) |
| Dec 1998 | $12.00 M(+114.3%) | $12.00 M(+48.1%) |
| Sep 1998 | - | $8.10 M(-28.9%) |
| Jun 1998 | - | $11.40 M(+533.3%) |
| Mar 1998 | - | $1.80 M(-67.9%) |
| Dec 1997 | $5.60 M(-71.3%) | $5.60 M(-42.3%) |
| Sep 1997 | - | $9.70 M(-22.4%) |
| Jun 1997 | - | $12.50 M(-23.3%) |
| Mar 1997 | - | $16.30 M(-16.4%) |
| Dec 1996 | $19.50 M(+23.4%) | $19.50 M(-14.1%) |
| Sep 1996 | - | $22.70 M(-6.6%) |
| Jun 1996 | - | $24.30 M(+85.5%) |
| Mar 1996 | - | $13.10 M(-17.1%) |
| Dec 1995 | $15.80 M(+19.7%) | $15.80 M(-14.1%) |
| Sep 1995 | - | $18.40 M(+119.0%) |
| Jun 1995 | - | $8.40 M(-21.5%) |
| Mar 1995 | - | $10.70 M(-18.9%) |
| Dec 1994 | $13.20 M(+29.4%) | $13.20 M(-14.8%) |
| Sep 1994 | - | $15.50 M(-12.9%) |
| Jun 1994 | - | $17.80 M(+74.5%) |
| Dec 1993 | $10.20 M | $10.20 M |
FAQ
- What is Armata Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual shareholders equity year-on-year change?
- What is Armata Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Armata Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ARMP is -$32.06 M
What is the all time high annual shareholders equity for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual stockholders equity is $63.43 M
What is Armata Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ARMP annual stockholders equity has changed by -$68.14 M (-188.87%)
What is Armata Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ARMP is -$50.97 M
What is the all time high quarterly shareholders equity for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly stockholders equity is $72.36 M
What is Armata Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ARMP quarterly stockholders equity has changed by -$38.59 M (-311.54%)